These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 11922706)
1. Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. Wharton SB; Chan KK; Whittle IR J Clin Neurosci; 2002 Mar; 9(2):165-9. PubMed ID: 11922706 [TBL] [Abstract][Full Text] [Related]
2. J1-31 protein expression in astrocytes and astrocytomas. Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178 [TBL] [Abstract][Full Text] [Related]
3. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424 [TBL] [Abstract][Full Text] [Related]
5. Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme. Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field JK; Spandidos DA In Vivo; 1991; 5(4):317-21. PubMed ID: 1667267 [TBL] [Abstract][Full Text] [Related]
6. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas. Gunal A; Onguru O; Safali M; Beyzadeoglu M Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442 [TBL] [Abstract][Full Text] [Related]
7. Proteomic studies on low- and high-grade human brain astrocytomas. Odreman F; Vindigni M; Gonzales ML; Niccolini B; Candiano G; Zanotti B; Skrap M; Pizzolitto S; Stanta G; Vindigni A J Proteome Res; 2005; 4(3):698-708. PubMed ID: 15952716 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. Tuccari G; Giuffrè G; Crisafulli C; Barresi G Eur J Histochem; 1999; 43(4):317-22. PubMed ID: 10682270 [TBL] [Abstract][Full Text] [Related]
9. Differential localization of high- and low-molecular-weight variants of microtubule-associated protein 2 in the developing rat telencephalon. Fujimori K; Takauji R; Tamamaki N J Comp Neurol; 2002 Aug; 449(4):330-42. PubMed ID: 12115669 [TBL] [Abstract][Full Text] [Related]
10. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors. Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861 [TBL] [Abstract][Full Text] [Related]
11. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach. Capper D; Mittelbronn M; Meyermann R; Schittenhelm J Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865 [TBL] [Abstract][Full Text] [Related]
12. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Sasaki T; Lopes MB; Hankins GR; Helm GA Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671 [TBL] [Abstract][Full Text] [Related]
13. High mobility group A1 expression correlates with the histological grade of human glial tumors. Donato G; Martinez Hoyos J; Amorosi A; Maltese L; Lavano A; Volpentesta G; Signorelli F; Pentimalli F; Pallante P; Ferraro G; Tucci L; Signorelli CD; Viglietto G; Fusco A Oncol Rep; 2004 Jun; 11(6):1209-13. PubMed ID: 15138557 [TBL] [Abstract][Full Text] [Related]
14. The expression of thyroid hormone receptor isoforms in human astrocytomas. Hwang SL; Lin CL; Lieu AS; Hwang YF; Howng SL; Hong YR; Chang DS; Lee KS Surg Neurol; 2008 Dec; 70 Suppl 1():S1:4-8; discussion S1:8. PubMed ID: 18617237 [TBL] [Abstract][Full Text] [Related]
15. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours. Hara A; Saegusa M; Ichinoe M; Okayasu I J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430 [TBL] [Abstract][Full Text] [Related]
17. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425 [TBL] [Abstract][Full Text] [Related]
18. Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry. Cao L; Cao W; Zhang W; Lin H; Yang X; Zhen H; Cheng J; Dong W; Huo J; Zhang X Neurosci Lett; 2008 Feb; 432(2):94-9. PubMed ID: 18242847 [TBL] [Abstract][Full Text] [Related]
19. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas. Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N Acta Neuropathol; 2005 Oct; 110(4):402-10. PubMed ID: 16155764 [TBL] [Abstract][Full Text] [Related]
20. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma. Hidaka T; Hama S; Shrestha P; Saito T; Kajiwara Y; Yamasaki F; Sugiyama K; Kurisu K Anticancer Res; 2009 Feb; 29(2):597-603. PubMed ID: 19331209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]